NSCEB Statement on Pentagon’s Updated 1260H List
The updated list includes Chinese biotechnology companies that have ties to the Chinese military and elevates U.S. biotechnology as a critical national security priority
10 June 2026
FOR IMMEDIATE RELEASE
Washington, DC – Today, the Chair and Vice Chair of the National Security Commission on Emerging Biotechnology (NSCEB), Senator Todd Young (R-IN) and Dr. Michelle Rozo, released a joint statement addressing the recently updated 1260H list of “Chinese military companies” operating directly or indirectly in the United States.
Joint statement from NSCEB Chair Senator Todd Young and Vice Chair Michelle Rozo:
“In April 2025, the NSCEB highlighted the vulnerability our current reliance on Chinese biotechnology firms creates for U.S. national security and called for a prohibition on the use of biotechnology suppliers that are deemed to pose a national security threat. We applaud the Pentagon for taking concrete steps this week to update its 1260H list with the addition of Chinese biotechnology companies that have known ties to the Chinese military. We must also reinforce the American biotech ecosystem, including through investing in alternatives to Chinese biotech companies of concern, so that our industry is built on a foundation of trusted suppliers and service providers.”
Read the NSCEB’s April 2025 Action Plan and roadmap for U.S. biotechnology here: www.biotech.senate.gov/final-report
About NSCEB: The National Security Commission on Emerging Biotechnology is a time-limited, high-impact legislative branch advisory entity whose purpose is to advance and secure biotechnology, biomanufacturing, and associated technologies for U.S. national security and to prepare the United States for the bioindustrial revolution. The Commission published a comprehensive report in April 2025, including recommendations for action by Congress and the federal government. The bipartisan Commission is composed of Congressionally-appointed Commissioners with members from both the Senate and the House of Representatives as well as experts from industry, academia, and government. For more information about the Commission and to view the report, visit: biotech.senate.gov.
Contacts:
NSCEB: press@biotech.senate.gov
